ArticleArXiv2024
Understanding YTHDF2-mediated mRNA Degradation By m
Ting-He Zhang, Sumin Jo, Michelle Zhang, Kai Wang, Shou-Jiang Gao, Yufei Huang
Open access · greenAbstract readPreprint
In one paragraphArticle in ArXiv, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
6 authors at 4 institutions in 1 country.
Ting-He ZhangCancer Virology Program, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Sumin JoCancer Virology Program, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Michelle ZhangDepartment of Electrical and Computer Engineering, The University of Texas at San Antonio, San Antonio, TX 78249, USA.
Kai WangRaymond G. Perelman Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Shou-Jiang GaoCancer Virology Program, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Yufei HuangCancer Virology Program, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
University of Pittsburgh · USUPMC Hillman Cancer Center · USChildren's Hospital of Philadelphia · USThe University of Texas at San Antonio · US
Funding
Regulation of KSHV replication by N6-methyladenosine (m6A) - Diversity SupplementR01CA124332 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GAO, SHOU-JIANG · 2007 to 2025
$5.0Mm6A-suite: an informatics pipeline and resource for elucidating roles of m6A epitranscriptome in cancerU01CA279618 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HUANG, YUFEI · 2023 to 2025
$1.8MUncovering the epitranscriptome regulatory codes using machine learningSC3GM136594 · NIGMS · UNIVERSITY OF TEXAS SAN ANTONIO · PI ZHANG, JIANQIU · 2020 to 2023
$435kNCI NIH HHS R01 CA124332NCI NIH HHS U01 CA279618NIGMS NIH HHS SC3 GM136594
6 · The paper itselfAbstract
Identifiers
PMID38292306
PMCPMC10827231
OpenAlexW4391009590
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390